Simon A. Broadley, Michael H. Barnett, Mike Boggild, Bruce J. Brew, Helmut Butzkueven, Robert Heard, Suzanne Hodgkinson, Allan G. Kermode, Jeannette Lechner-Scott, Richard A.L. Macdonell, Mark Marriott, Deborah F. Mason, John Parratt, Stephen W. Reddel, Cameron P. Shaw, Mark Slee, Judith Spies, Bruce V. Taylor, William M. Carroll, Trevor J. Kilpatrick, John King, Pamela A. McCombe, John D. Pollard, Ernest Willoughby. (2014) Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations. Journal of Clinical Neuroscience 21, 1857-1865
CrossRef
A.J. Ullmann, M. Akova, R. Herbrecht, C. Viscoli, M.C. Arendrup, S. Arikan-Akdagli, M. Bassetti, J. Bille, T. Calandra, E. Castagnola, O.A. Cornely, J.P. Donnelly, J. Garbino, A.H. Groll, W.W. Hope, H.E. Jensen, B.J. Kullberg, C. Lass-Flörl, O. Lortholary, W. Meersseman, G. Petrikkos, M.D. Richardson, E. Roilides, P.E. Verweij, M. Cuenca-Estrella. (2012) ESCMID* *This guideline was presented in part at ECCMID 2011. European Society for Clinical Microbiology and Infectious Diseases. guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). Clinical Microbiology and Infection 18, 53-67
CrossRef
Roy A. Beveridge, John A. Miller, Arthur N. Kales, Richard A. Binder, Nicholas J. Robert, Jimmie H. Harvey, Kevin Windsor, Ira Gore, James Cantrell, Keith A. Thompson, William R. Taylor, Harry M. Barnes, Steven A. Schiff, John A. Shields, Richard J. Cambareri, Thomas P. Butler, Robert J. Meister, John M. Feigert, Michael J. Norgard, Manoel A. Moraes, William W. Helvie, Gregory A. Patton, Larry J. Mundy, David Henry, Bernard Mason, Arthur Staddon, Patricia Ford, Daniel Katcher, William Houck, William B. Major, Nicholas W. Gemma, Gary Kay, Edwin Priest, Paul Sowroy, Bruce Bank, Steven Leibach, Herbert Reisel, Gary Grad, Robert D. Warren, Winston M. Ueno, Lee F. Smith, Robert F. Dobrzynski, Michael J. Sheridan. (1998) A Comparison of Efficacy of Sargramostim (Yeast-Derived RhuGM-CSF) and Filgrastim (Bacteria-Derived RhuG-CSF) in the Therapeutic Setting of Chemotherapy-Induced Myelosuppression. Cancer Investigation 16, 366-373
CrossRef